GlassScriptPhysician profile
John Mose Roberts
NPI 1023270733
$4,333.70
in general payments reported to CMS, 2019-2025
25 companies · $336 in 2025
The $336 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $667 · 2021: $659 · 2022: $825 · 2023: $522 · 2024: $597 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,048.50 | 2019-2025 | Clareon, Hydrus Microstent, Centurion |
| Abbvie INC. | $458.94 | 2022-2025 | Ozurdex, Alphagan P, Lumigan |
| Novartis Pharmaceuticals Corporation | $297.45 | 2019-2023 | |
| Glaukos Corporation | $260.27 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3, Idose |
| Allergan, INC. | $252.97 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $167.61 | 2020-2021 | |
| Eyepoint US, INC. | $157.98 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $70.72 | 2023-2025 | Eylea Hd, Eylea |
| Johnson & Johnson Vision Care, INC. | $69.76 | 2019 | |
| Genentech USA, INC. | $61.53 | 2019-2023 | Vabysmo |
| Vantage Technology LLC | $54.91 | 2023-2025 | |
| Astellas Pharma US INC | $54.86 | 2023-2024 | Izervay |
| Sun Pharmaceutical Industries INC. | $47.51 | 2021-2022 | |
| Ocular Therapeutix, INC. | $44.83 | 2020-2022 | |
| Oyster Point Pharma, INC. | $42.67 | 2023 | Tyrvaya |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $41.12 | 2021 | |
| Mallinckrodt Hospital Products INC. | $33.68 | 2021-2023 | Acthar |
| Bausch & Lomb Americas INC. | $33.68 | 2022 | |
| Shire North American Group INC | $24.92 | 2019 | |
| Coopervision INC. | $23.21 | 2023 | Myday Contact Lens |
| Kala Pharmaceuticals, INC. | $22.24 | 2021 | |
| Optos, INC. | $18.50 | 2020 | |
| Ani Pharmaceuticals, INC. | $16.52 | 2024 | Purified Cortrophin Gel |
| Biotissue Holdings INC. | $16.01 | 2021 | |
| Harrow Eye, LLC | $13.31 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.